Bisphenol A and pharmacological ERβ inhibition impair follicular maturation and acquisition of ovulatory competence at human follicular fluid exposure levels in a three-dimensional follicle culture model
Bisphenol A (BPA) is a ubiquitous endocrine disruptor that impairs female fertility, yet the specific mechanisms through which it disrupts the terminal stages of ovulation are not fully understood. This study investigated the effects of BPA on follicular maturation and ovulatory competence using a three-dimensional (3D), alginate-based follicle culture system, focusing on the role of estrogen receptor beta (ERβ). Late preantral rat follicles were exposed to BPA (0.15 µg/mL) and/or the selective ERβ antagonist PHTPP (0.65 pM). BPA significantly reduced the ovulation rate from approximately 80% in controls to ~20%. Notably, low-dose PHTPP alone also markedly suppressed ovulation, indicating that minimal disruption of ERβ signaling compromises follicular functional integrity. Gene expression analysis revealed that successful ovulation was associated with a coordinated upregulation of gonadotropin-responsive and steroidogenic genes, including Cyp11a1, Cyp17a1, Cyp19a1, Fshr, and Lhcgr. In contrast, non-ovulated follicles failed failed to activate this transcriptional program, were unable to mount an estradiol (E2) response, and exhibited evidence of reduced FSH responsiveness. Our findings suggest that BPA impairs ovulation by disrupting the coordination between follicular growth and functional maturation. Together, our results demonstrate that BPA directly impacts ovarian function at concentrations relevant to human follicular fluid (FF) exposure, through mechanisms converging on pathways essential for ERβ-regulated follicular differentiation.